Search      Advanced Search | Browse By Topic
Magazine Content
Home
Features
Columnists
Industry Risk Reports
In-Depth Series
Special Reports
Point/Counterpoint
R&I One® Content
News & Analysis
Editor's Choice Stories
Resources and Tools
Power Broker® Directory
Risk InnovatorTM
Emerging Risks
Top Employee Benefits Consultant
Executives To Watch
Insights
Industry Events
WorkersComp Forum
Award Nominations
Webinars
RSS
R&I Information
Subscription Center
Advertiser Information
About Us
Contact Us
 

Newsletter Sign-up

Click on the name of the free newsletter below to preview:

R&I One®
WORKERSCOMP Forum TM Update
HTML Text
E-Mail Address:


Click here to unsubscribe
Privacy Policy
Preferences

 

New York AG seeks to ramp up fight against prescription drug abuse

Physicians and pharmacists would be required to submit information and consult an online database before dispensing narcotics under a new proposal. New York Attorney General Eric T. Schneidermann is hoping to enhance the state's prescription drug monitoring program.

Print Email Add to Facebook Add to Twitter Add to LinkedIn Write to the Editor Reprints

With narcotics abuse one of the most oft-cited concerns in the workers' comp system, some stakeholders have sought help from state regulators. Schneidermann's proposal aims to combat prescription drug abuse.

The problem has been growing in recent years. Schneidermann's office reports the use of oxycodone prescriptions rose 66 percent in New York City alone from 2007 to 2009. Another opioid, Opana ER, has increased in use in Nassau County, N.Y., since the manufacturer of OxyContin altered its formula to prevent abuse.

The proposed Internet System for Tracking Over Prescribing Act, or I-STOP, would create an online database to provide real-time, centralized information on certain controlled substances. Health care practitioners and pharmacists would be required to do the following:

  • Report specific information when Schedule II, III, IV and V controlled substances are prescribed and dispensed. Schedule II substances include oxycodone and morphine; Schedule III includes vicodin; Schedule IV includes Xanax and Klonopin; and Schedule V includes pyrovalerone.
  • Consult the database before prescribing and dispensing a Schedule II, III, IV or V drug.
  • Complete continuing education programs on the proper uses of the substance reporting system.

Physicians will be able to ensure a prescription is medically necessary and that the patient is not an addict or habitual user. Pharmacists will be able to ensure the prescription presented matches the data reported by a practitioner to the I-STOP database.

The legislation would prohibit the disclosure of all the data collected in the online database unless authorized by law. Officials say the proposal will help crack down on doctor shopping, where patients visit several physicians and pharmacies for prescription drugs.

"With real-time information, physicians and pharmacists will be able to track potential abuses, treat addiction, and stop those who enable and profit off of the illegitimate use of prescribed drugs," according to a statement from Schneidermann's office.

Forty-three states have prescription drug monitoring programs in place. There is a proposal in Congress to create a national prescription drug database.

Read more at the WorkersComp Forum homepage.

July 5, 2011

Copyright 2011© LRP Publications

 
 
 
 
 
 
 
 
 
 
 
RISK logo
 

Back to top

Entire contents copyright © 2013 Risk and Insurance® All rights reserved. May not be reproduced in any form without written permission.